Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miner

Showing results (231-240 of 3,267) with videos related to

Pageof 327
Sort By:
Cancer Treatment and Research|July 18, 2007
The impact of therapy in the treatment of pseudomyxoma peritoneiT J Miner
Mayo Clinic Proceedings|February 3, 2009
Erectile dysfunction and the "window of curability": a harbinger of cardiovascular eventsMartin M Miner
Drug Safety|January 17, 2019
Benefit-Risk Assessment of Plecanatide in the Treatment of Chronic Idiopathic ConstipationPhilip B Miner
Expert Review of Gastroenterology & Hepatology|January 28, 2020
Plecanatide for the treatment of constipation-predominant irritable bowel syndromePhilip B Miner
The American Journal of Gastroenterology|November 8, 2017
Response to Currie et alPhilip B Miner
The Journal of Nursing Education|October 30, 2014
Informatics assignment for graduate nursing practice studyAmy Miner Ross
Expert Opinion on Pharmacotherapy|January 30, 2018
Efficacy and safety of plecanatide in treating constipation predominant irritable bowel syndromePhilip B Miner
Journal of Youth and Adolescence|November 23, 2013
The self-concept of homeless adolescentsM H Miner
The Journal of Investigative Dermatology|March 1, 1991
The role of the mast cell in clinical gastrointestinal disease with special reference to systemic mastocytosisP B Miner
The American Journal of Gastroenterology|December 12, 1997
Factors influencing the relapse of patients with inflammatory bowel diseaseP B Miner
Pageof 327

Showing results (231-240 of 3,267) with videos related to

Sort By:
Pageof 327
Cancer Treatment and Research|July 18, 2007
The impact of therapy in the treatment of pseudomyxoma peritoneiT J Miner
Mayo Clinic Proceedings|February 3, 2009
Erectile dysfunction and the "window of curability": a harbinger of cardiovascular eventsMartin M Miner
Drug Safety|January 17, 2019
Benefit-Risk Assessment of Plecanatide in the Treatment of Chronic Idiopathic ConstipationPhilip B Miner
Expert Review of Gastroenterology & Hepatology|January 28, 2020
Plecanatide for the treatment of constipation-predominant irritable bowel syndromePhilip B Miner
The American Journal of Gastroenterology|November 8, 2017
Response to Currie et alPhilip B Miner
The Journal of Nursing Education|October 30, 2014
Informatics assignment for graduate nursing practice studyAmy Miner Ross
Expert Opinion on Pharmacotherapy|January 30, 2018
Efficacy and safety of plecanatide in treating constipation predominant irritable bowel syndromePhilip B Miner
Journal of Youth and Adolescence|November 23, 2013
The self-concept of homeless adolescentsM H Miner
The Journal of Investigative Dermatology|March 1, 1991
The role of the mast cell in clinical gastrointestinal disease with special reference to systemic mastocytosisP B Miner
The American Journal of Gastroenterology|December 12, 1997
Factors influencing the relapse of patients with inflammatory bowel diseaseP B Miner
Pageof 327